ARCHIVES

In Brief: Conferees Ok NCI Appropriations At $691.7 Million; Final Amount Available Won’t Be Set Until Spring

This article is from The Cancer Letter archive.

Vol. 01 No. 43 | November 29, 1974

Download PDF Visit The Full Archive

Related Articles

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

In Brief: Discoverer Of H. Pylori Role In Ulcers Wins Lasker Foundation Clinical Research Award

October 6, 1995

In Brief: THOMAS BURKE Stepped Down As Executive Vice President And Physician-In-Chief at MD Anderson Cancer Center To Accept The New Position Of Executive Vice President of the MD Anderson Cancer Network

December 13, 2013

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992